Neeraj Agarwal

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

Neeraj Agarwal
Sep 17, 2024, 10:06 | Insight
Sumanta K. Pal: Important analysis of SWOG 1500 published just ahead of ESMO24
Sumanta K. Pal shared a post on X: "Huge congrats to Pedro C Barata, who drove…
Sep 16, 2024, 16:31 | Societies
40 Posts Not To Miss From ESMO24 Day 3
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 15, 2024, 15:58 | Blog
OncoInfluencers to Follow on Social Media: Dr. Neeraj Agarwal
We are delighted to feature Dr. Neeraj Agarwal as a key figure in the oncology…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Sep 14, 2024, 17:15 | Societies
45 Posts not to miss from ESMO24 Day 1
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…
Sep 14, 2024, 13:44 | Societies
Neeraj Agarwal's highlights from ESMO24
The ESMO Congress 2024 (ESMO24) is one of the most globally influential platforms in oncology,…
Sep 13, 2024, 07:51 | Blog
Neeraj Agarwal: Zr-girentuximab PET–CT for detecting ccRCC
Neeraj Agarwal shared a post on X, about recent paper published in The Lancet Oncology:…
Sep 7, 2024, 15:45 | Blog
Dimitra R. Bakaloudi: Evaluating TMB and MSI in patients with Urothelial cancer treated with ICIs
Dimitra R. Bakaloudi, Postdoctoral GU Oncology Researcher at University of Washington, shared on X about…
Sep 7, 2024, 10:04 | Blog
Jun Gong: Selective omission of RT in rectal cancer
Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared on X:…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Aug 18, 2024, 08:27 | Blog
Enrique Grande: Amazing review from Rana McKay and Neeraj Agarwal on the new PARPi + ARSIs combos
Enrique Grande posted on X about recent paper by Rana McKay et al., titled "First-line…
Aug 11, 2024, 12:27 | Insight
Avirup Guha: SDOH's impact on hypertension control in cancer patients
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X about a recent…
Aug 10, 2024, 14:33 | Insight
Importance of early genetic testing for prostate cancer patients
Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…
Aug 10, 2024, 12:17 | Insight
Emmanuel Antonarakis: Most compelling study suggesting that combined Abiraterone and Olaparib is better than sequential Abiraterone and Olaparib for 1st-line mCRPC
Emmanuel Antonarakis, Professor of Medicine at the University of Minnesota, shared a post on X…
Aug 5, 2024, 02:16 | Blog
Neeraj Agarwal: Biomarker based treatment of bladder cancer
Neeraj Agarwal shared a post on X: "Biomarker based treatment of bladder cancer. Enjoyed the…
Aug 5, 2024, 01:55 | Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Aug 4, 2024, 17:24 | Blog
Neeraj Agarwal: Liquid epigenomic profiling to diagnose RCC patients with residual disease surgery
Neeraj Agarwal shared on X: "Another stellar talk by David Braun in World GU Conference…
Aug 4, 2024, 16:52 | Insight
Future of ADCs and targeted therapies in bladder cancer
Neeraj Agarwal shared a post on X: “Future of ADCs and targeted therapies in bladder…
Aug 4, 2024, 14:30 | Societies
8 Posts Not To Miss From GUWorld24!
The 2024 World Conference On Genitourinary Cancers (GUWorld24) took place from August 1st to 3rd…
Aug 4, 2024, 12:48 | Insight
Neeraj Agarwal: Recommendations on bladder preservation in MIBC at the WorldGU24
Neeraj Agarwal shared on X: “Recommendations on bladder preservation in MIBC bladder-cancer by the IBCG…
Jul 25, 2024, 13:04 | Blog
Enrique Grande: Failure of Trials to Enhance Outcomes in mRCC Patients Re-challenged with Immunotherapy
Enrique Grande shared a post on X: "2 phase 3 trials have failed to improve…
Jul 24, 2024, 13:22 | Insight
Neeraj Agarwal: Unacceptably low rates of NGS testing in metastatic Prostate Cancer
Neeraj Agarwal shared a post on X about a recent paper by Chadi Hage Chehade…
Jul 24, 2024, 13:13 | Blog
Earle Burgess: Bipolar androgen therapy for advanced prostate cancer
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared on LinkedIn: "Bipolar androgen therapy…
Jul 21, 2024, 20:01 | Blog
Assessing bone pain and survival in SWOG Cancer Research Network 1216 TAK700 in hormone sensitive prostate cancer
Sumanta K.Pal shared a post on X about a recent paper by Georges Gebrael et al.,…
Jul 21, 2024, 10:58 | Blog
Chadi Hage Chehade: NGS testing rates in patients with metastatic prostate and urothelial cancers
Petros Grivas shared a post by Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, on X:…
Jul 20, 2024, 21:28 | Blog
Pedro C Barata: More awesome news for patient with mCRPC
Pedro C Barata, GU Med Oncologist at University Hospitals Seidman Cancer Center, posted on X:…
Jul 20, 2024, 01:26 | Blog
Two recent papers studying BRAF alterations in PCa
Recently two papers have been published about BRAF alterations in prostate cancer: Unique Spectrum of…
Jul 14, 2024, 06:27 | Blog
Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Jul 14, 2024, 03:00 | Insight
Comprehensive talk on treatment options in adjuvant RCC by Bradley McGregor
Neeraj Agarwal shared on X: "Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive…
Jul 13, 2024, 20:46 | Blog
Yüksel Ürün: Outstanding presentation at KCRS24 Rohit Mehra
Yüksel Ürün shared on X: "Outstanding presentation at KCRS 24 Rohit Mehra Role of Pathologist…
Jul 12, 2024, 16:05 | Insight
Piotr Wysocki: Bone Pain and Survival Among Patients With mHSPC
Piotr Wysocki recently posted on LinkedIn: "Bone pain is linked to worse overall survival (OS) in…
Jul 12, 2024, 13:32 | Societies
Insights from KCRS24 by Neeraj Agarwal
Kidney Cancer Research Summit or the KCRS24 was a conference held on 11th-12th July in…
Jul 11, 2024, 11:33 | Blog
Neeraj Agarwal: Outstanding talk by Evan Yu on treatment of advanced prostate cancer
Neeraj Agarwal shared a post on X: “Enjoyed the outstanding talk by Evan Yu at…
Jul 11, 2024, 10:12 | Blog
Shilpa Gupta: Stellar talk by Neeraj Agarwal on tremendous progress in mCRpC in Athens
Shilpa Gupta shared a post on X: “Stellar talk by Neeraj Agarwal on tremendous progress…
Jul 11, 2024, 03:10 | Blog
Neeraj Agarwal: A terrific whirlwind tour of bladder cancer treatment landscape by Shilpa Gupta
Neeraj Agarwal shared a post on X: “A terrific whirlwind tour of bladder cancer treatment…
Jul 8, 2024, 12:15 | Insight
Neeraj Agarwal: Authoritative talk on systemic treatment of penile cancer by Andrea Necchi
Neeraj Agarwal shared a post on X: "Authoritative talk on systemic treatment of penile cancer…
Jul 8, 2024, 12:07 | Blog
Shilpa Gupta: Kudos to Philippe Spiess and Andrea Necchi on the successes of Global Society of Rare GU Tumors
Shilpa Gupta shared on X: "The amazing Philippe Spiess kicks off the session on rare…
Jul 4, 2024, 12:08 | Societies
Neeraj Agarwal and Rana McKay highlight key studies in urothelial and renal cell carcinomas
The American Society of Clinical Oncology (ASCO) shared on X: "Neeraj Agarwal of Huntsman Cancer…
Jul 3, 2024, 23:28 | Insight
Neeraj Agarwal: Amazing performance by the stellar Genitourinary Cancer Research Team's junior investigators
Neeraj Agarwal shared a post on X: "Amazing performance by the stellar Genitourinary Cancer Research…
Jul 1, 2024, 12:00 | Blog
Shilpa Gupta: Congrats Neeraj Agarwal on another stellar achievement
Shilpa Gupta shared on X/Twitter: "Congrats Neeraj Agarwal on yet another stellar achievement! And for…
Jun 24, 2024, 01:48 | Insight
Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer
UroToday shared a post on X:           . "The EvoPAR-Prostate 01 Trial:…
Jun 24, 2024, 00:16 | Blog
Huntsman Cancer Institute Collaborative Award for RO1 grant  
Umang Swami, Assistant Professor at Huntsman Cancer Institute, University of Utah, shared a post on X:…
Jun 22, 2024, 03:01 | Blog
Yüksel Ürün: Join Second International Urology Cancer Summit in Portsmouth
Yüksel Ürün shared on LinkedIn: "Save the Date! Join us at the Second International Urology…
Jun 21, 2024, 10:56 | Blog
Petros Grivas: Always impressed by servant leadership of brilliant Neeraj Agarwal
Petros Grivas shared on X/Twitter: "Always impressed by servant leadership of brilliant Neeraj Agarwal including tremendous…
Jun 20, 2024, 06:25 | Blog
Petros Grivas: Congratulations Neeraj Agarwal Neal Shore and all authors!
Petros Grivas shared a post by Neeraj Agarwal, on X: "Congratulations Neeraj Agarwal Neal Shore and all…
Jun 17, 2024, 13:17 | Insight
Neeraj Agarwal: Expert guidance on management of AEs in patients with prostate cancer
Neeraj Agarwal shared on X/Twitter: "Just in European Urology Oncology. Expert guidance (by modified Delphi panel…
May 30, 2024, 08:57 | Blog
Neeraj Agarwal: RCT trial of GAIN-S vs usual care in older patients with cancer
Neeraj Agarwal shared a post on X/Twitter: ''Oral Ab#1514 at ASCO24 by Cristiane Bergerot. RCT…
May 29, 2024, 07:46 | Societies
Sumanta Pal: If there's one person who I lean on the most for my ASCO24 experience, it's Neeraj Agarwal
Sumanta Pal shared on X: "If there's one person who I lean on the most…
May 27, 2024, 11:20 | Blog
Neeraj Agarwal: Our official ASCO Daily News Podcast highlighting some GU abstracts ASCO24
Arun Azad, Consultant Medical Oncologist at Peter MacCallum Cancer Centre, shared a post by Neeraj…
May 27, 2024, 08:36 | Societies
Giuseppe Banna: The Second International Urology Cancer Summit will take place in Portsmouth on September 27, 2024
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, recently shared a post…
May 26, 2024, 06:02 | Insight
Toni Choueiri: The work of Eddy Saad, Eli Van Allen, Sasha Gusev being highlighted here at ASCO24
Toni Choueiri shared a post by Neeraj Agarwal on X/Twitter: "The work of Eddy Saad, Eli Van…
May 25, 2024, 12:37 | Blog
Neeraj Agarwal: Camrelizumab+apatinib in previously treated pts w/ advanced adrenocortical cancer by Zhigong Wei
Neeraj Agarwal shared a post on X: “Ab#4511 ASCO ASCO 24 by Zhigong Wei. Camrelizumab+apatinib ph2…
May 25, 2024, 07:09 | Societies
Neeraj Agarwal summarizes some Abstracts of ASCO24
Neeraj Agarwal shared on X: Abstract #5010 by Michael Morris Phase 1 study of Actinium-225-labeled…
May 24, 2024, 15:23 | Blog
Neeraj Agarwal: Join us for the Research To Practice Prostate Cancer program on ASCO24
Sumanta Pal shared a post by Neeraj Agarwal on X/Twitter: "With Neeraj Agarwal on the program,…
May 19, 2024, 05:13 | Blog
Estela Rodriguez: Join us for this Panel Discussion on Careers in Oncology Academia during ASCO24
Estela Rodriguez shared on X: "Why are we smiling? Because we like our jobs in…
May 14, 2024, 02:29 | Blog
Shilpa Gupta: Honored to be panel member for this highly productive San Raffaele Hospital retreat with esteemed experts!
Shilpa Gupta, Director GU Oncology at Cleveland Clinic MD, shared a post by Andrea Necchi, Associate Professor…
May 2, 2024, 08:36 | Insight
Chadi Hage Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
May 1, 2024, 11:48 | Insight
Chadi Chehade: Happy to share our editorial recently published in Cancer Cell!
Chadi Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, shared a post by Neeraj Agarwal…
Apr 30, 2024, 18:17 | Blog
Neeraj Agarwal: The latest in the mHSPC prostate cancer
Neeraj Agarwal shared a post by MedscapeLIVE, on X: "The American Urological Association, AUA24, MedscapeLIVE meeting, Friday,…
Apr 30, 2024, 14:14 | Blog
Neeraj Agarwal: Excellent talk by Heather Cheng at APCCC24
Neeraj Agarwal shared a post on X: "Excellent talk by Heather Cheng on who should…
Apr 30, 2024, 11:54 | Societies
15 Posts Not To Miss from APCCC24!
The Advanced Prostate Cancer Consensus Conference 2024 (APCCC24) was held from April 25th to April…
Apr 30, 2024, 10:34 | Blog
Neeraj Agarwal: Validation of Molecular Clusters in JAVELIN Renal 101 Dataset: Commentary by Chadi Hage Chehade
Neeraj Agarwal shared a post on X: "Just in Cancer Cell. Validation of the molecular clusters…
Apr 27, 2024, 11:23 | Insight
APCCC24 Highlights: Lutetium-177 PSMA RLT Toxicity Management by Neeraj Agarwal
Neeraj Agarwal shared on X/Twitter: "How to monitor and manage toxicities with Lutetium-177 PSMA RLT? Luis…
Apr 27, 2024, 09:53 | Blog
Neeraj Agarwal: Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation therapy in high risk Prostate Cancer
Neeraj Agarwal shared on X/Twitter: "Advanced Prostate Cancer Consensus Conference, Fantastic talk by Neha Vapiwala on radiation…
Apr 23, 2024, 16:51 | Insight
Neeraj Agarwal: Full protocol of our trial of creatine supplementation and resistance training in advanced prostate cancer undergoing ADT
Neeraj Agarwal shared on X: "Just in BioMed Central! Full protocol of our recently initiated,…
Apr 15, 2024, 12:07 | Blog
Neeraj Agarwal: A comprehensive review of PARPi+ARPI combos in 1st line mCRPC
Neeraj Agarwal shared a post on X: "Just in A comprehensive review of PARPi+ARPI combos…
Apr 14, 2024, 14:15 | Insight
Neeraj Agarwal: Data from SWOG 1216 trial in mHSPC
Neeraj Agarwal shared on X/Twitter: "Just in: Data from SWOG Cancer Research Network 1216 trial…
Apr 7, 2024, 11:45 | Drugs
Yüksel Ürün: Adding immunotherapy to cabozantinib for mccRCC after 1st line immunotherapy showed no extra benefit in real-world data
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared a post…
Apr 4, 2024, 14:05 | Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Apr 4, 2024, 13:47 | Insight
Sumanta K. Pal: Excellent real world confirmation of our observations in CONTACT03
Sumanta K. Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared…
Apr 1, 2024, 19:03 | Blog
Top Influencers in GU Ocology by LARVOL
LARVOL shared on their X/Twitter page: "Delving into GU Oncology, we’re thrilled to spotlight the…
Feb 25, 2024, 16:11 | Insight
Aruni Ghose: Delighted to see our prospective blinded validation trial on the URO17 urinary bladder cancer biomarker published in BMC Urology by Springer Nature Group
Aruni Ghose, Focused Topic Network Member at European Cancer Organisation, shared a post on LinkedIn: ''Delighted…
Feb 11, 2024, 12:01 | Insight
Vinay Mathew Thomas: Our viewpoint article on CheckMate 901 is now out in Med by Cell Press
Petros Grivas, Associate Professor at the University of Washington, shared an X post by Vinay…
Jan 29, 2024, 13:54 | Blog
Yousef Zakharia: The Right Person in the Appropriate Position as Editor in Chief for ASCO DailyNews
Yousef Zakharia, Associate Professor of Medicine at The University of Iowa shared a post by…
Jan 28, 2024, 18:54 | Societies
10 posts from ASCO GU 2024 by Yüksel Ürün
Yüksel Ürün, Professor of Medical Oncology at Ankara University, has recapped ASCO GU highlights on…
Jan 10, 2024, 18:21 | Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
Dec 5, 2023, 19:09 | Insight
Neeraj Agarwal: Results from Ph3 TALAPRO-2 trial in 399 pts w/ HRR-deficient mCRPC prostate cancer
Neeraj Agarwal shared the following on Twitter: “Just in Nature Medicine: Results from Ph3 TALAPRO-2…
Nov 9, 2023, 19:17 | Opinion
Vivek Subbiah: Feeling grateful to have a brilliant and forward-thinking global expert in GU as a close friend Neeraj Agarwal
Vivek Subbiah, Chief of Early-Phase Drug Development at the  Sarah Cannon Research Institute, posted the following…
Nov 6, 2023, 22:47 | Blog
Vivek Subbiah: We've been to the moon, now we need to go to Mars and beyond to eradicate cancer
Vivek Subbiah, posted the following on Twitter: What is the best way to spend that extra…
Sep 28, 2023, 20:32 | Blog
Vivek Subbiah: So much enthusiasm for delivering Precision Medicine every where.
Vivek Subbiah, made the following post on LinkedIn: "Delighted to visit Park City, Utah to deliver…
All: 80 Posts: 1 - 100
Special Coverage